alexa The Importance of Species Identification in Acinetobacter | Open Access Journals
ISSN: 2161-0703
Journal of Medical Microbiology & Diagnosis
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

The Importance of Species Identification in Acinetobacter

Hilmar Wisplinghoff *

Institute for Medical Microbiology Immunology and Hygiene, University of Cologne, Germany

*Corresponding Author:
Hilmar Wisplinghoff
Institute for Medical Microbiology
Immunology and Hygiene
University of Cologne, Germany
E-mail: [email protected]

Received date: August 27, 2012; Accepted date: August 28, 2012; Published date: August 30, 2012

Citation: Wisplinghoff H (2012) The Importance of Species Identification in Acinetobacter. J Med Microb Diagn 2:e113. doi:10.4172/2161-0703.1000e113

Copyright: © 2012 Wisplinghoff H . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Medical Microbiology & Diagnosis

Abstract

 #

Acinetobacter species have emerged as one of the most important pathogens in recent years. The clinical relevance of the genus–more precisely several species of this genus–has constantly risen in the past thirty years. Currently the species of the Acinetobacter baumannii group, i.e. A. baumannii, A. pittii (formerly Acinetobacter genomic species 3) and A. nosocomialis (formerly Acinetobacter genomic species 13), belong to the most resistant organisms known to cause relevant infections in man.

The genus Acinetobacter consists of 31 species, 22 of which have been assigned species names. These species differ widely in their epidemiology, natural habitat, and clinical relevance. While some species such as A. schindleri or A. ursingii have so far been only isolated from human specimens, others like A. baylyi or A. towneri have only been found in activated sludge or environmental specimens and have never been described as a causative pathogen of an infection in humans.

Much like the genus of the staphylococci where Staphylococcus aureus stands out as one of the clinically most important pathogens, and S. lugdunensis and S. saprophyticus are regularly associated with infections, while most other species of the genus are of minorclinical importance, there are important differences in the clinical relevance of the individual Acinetobacter species.

A. baumannii and to some extend the other members of the A. baumannii group (A. pittii and A. nosocomialis) are important nosocomial pathogens that have been associated with a variety of nosocomial infections, mainly in immunocompromised patients in the ICU setting. Clinical presentation of these infections ranges from benign transient infections to fulminant septic shock and can be associated with high mortality. In contrast, the other Acinetobacter species (“A. non-baumannii species”) are of minor clinical relevance and can be regarded a largely non-pathogenic environmental organism.

Unfortunately, in Acinetobacter species, identification to species level is complicated, and none of the routinely used biochemical methods (including the automated systems) is able to clearly differentiate between the individual Acinetobacter species. Reference methods such as specially adopted biochemical panels and molecular methods are either not available or not regularly employed in most of the routine diagnostic laboratories. MALDI-TOF MS may be a solution to this problem, however, on one hand current data are sparse and the results of different studies vary, on the other hand, MALDI-TOF is not yet widely used.

This problem is not only of clinical relevance–here surprisingly less so, since most currently used systems mange to correctly differentiate between A. baumannii group and the other species - but continues to lead to some confusion in the scientific environment.

Several papers–regardless of the quality or impact of the publishing journal–still confuse the pathogenic species A. baumannii (that is almost exclusively isolated from human specimens) with the ubiquitous A. non-baumannii species. Depending on the focus of the studies, incorrect species identification can have a tremendous impact on the results especially if clinical features or resistance rates are reported. Also, most of the epidemiological methods will provide results independently of the investigated species, and problems in the species identification - and therefore the selection of strains to be included in the study - can also considerably alter the results.

In order to expand the knowledge of clinical features and epidemiology of the different Acinetobacter species, all studies should employ reference methods to correctly (re-)identify all included Acinetobacter strains at species level.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 10th World Congress on Alzheimers Disease & Dementia
    May 30-31, 2018 Osaka, Japan
  • 4th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
    June 14-15, 2018 Barcelona, Spain
  • 4th Annual Congress on Infectious Diseases  
    September 17-18, 2018 San Diego, USA
  • 13th World Congress on Virology
    September 26-27, 2018 Montreal, Canada

Article Usage

  • Total views: 11676
  • [From(publication date):
    January-2013 - Nov 24, 2017]
  • Breakdown by view type
  • HTML page views : 7890
  • PDF downloads : 3786
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords